President Biden Appoints DF/HCC Member, Kimberly Stegmaier, MD (DFCI), to National Cancer Advisory Board
October 30, 2024
On October 15, 2024 President Joe Biden announced his intent to appoint several individuals to serve in key roles.
Click here to read the full article.
Kimberly Stegmaier, MD (DFCI) was appointed by President Biden to the National Cancer Advisory Board, which helps guide the director of the National Cancer Institute in setting the course for the national cancer research program and Cancer Moonshot project.
Kimberly Stegmaier, MD, Professor of Pediatrics at Harvard Medical School, and the Ted Williams Investigator at Dana-Farber Cancer Institute, has pioneered the development and application of innovative genomic approaches to identify new therapies for childhood cancer. Her lab has discovered novel technologies, concepts, and targets with translational impact. Stegmaier is the Vice Chair for Pediatric Oncology Research, Co-Director of the Pediatric Hematologic Malignancy Program, and provides clinical care in pediatric oncology at the Dana-Farber Cancer Institute and Boston Children’s Hospital. Stegmaier is an Institute Member of the Broad Institute of Harvard and MIT where she serves on the Cancer Program’s Scientific Advisory Committee, and she is a Board Member of the American Association for Cancer Research.
Stegmaier is the recipient of numerous awards, such as the Joanne Levy, MD, Memorial Award for Outstanding Achievement from the American Society of Hematology, a Stand Up To Cancer (SU2C) Innovative Research Grant, an E. Mead Johnson Award for Research in Pediatrics, and an NCI Outstanding Investigator R35 Award. She was elected to the American Society of Clinical Investigation and the Association of American Physicians. Her deep commitment to training the next generation of researchers has been recognized with the A. Clifford Barger Excellence in Mentoring Award from Harvard Medical School and the Casty Family Achievement in Mentoring Award from the Dana-Farber Cancer Institute. Stegmaier received her undergraduate degree from Duke University, medical degree from Harvard Medical School, and trained in Pediatrics and Pediatric Hematology/Oncology at Boston Children’s Hospital and the Dana-Farber Cancer Institute.